<DOC>
<DOCNO>1070519_business_story_7799385.utf8</DOCNO>
<TEXT>


The Telegraph - Calcutta : Business

 Dr Reddys net leaps

 A STAFF REPORTER

 Healthy results

 Calcutta, May 18: Dr Reddys Laboratories today reported a 472 per cent jump in net profit at Rs 932.7 crore for the financial year 2006-07 against Rs 163 crore in the year-ago period. Revenues for the reporting year at Rs 6,509.5 crore showed a rise of 168 per cent over previous years Rs 2,400 crore.

 International sales, particularly in the North American markets, contributed significantly to the companys annual revenues. While its domestic revenues grew only 11 per cent over the previous year to Rs 917.9 crore from Rs 827.2 crore, sales in North America jumped over 600 per cent to Rs 2,833.7 crore. In the European market too, Dr Reddys did well where its sales registered a growth of 243 per cent at Rs 1,483.9 crore. 

 In 2005-06, domestic sales made up 34 per cent of DRLs total revenues, while the shares of the North American and European markets were 16 per cent and 18 per cent, respectively. In 2006-07, the share of the domestic revenue in total sales slipped to 14 per cent, while that of the North American and European markets went up to 44 per cent and 23 per cent, respectively.

 Revenues, excluding that from authorised generic drugs and acquisitions, increased 58 per cent to Rs 3,600 crore from Rs 2,300 crore in the previous year, a company release said.

 Of its total revenue in 2006-07, authorised generic drug sales contributed 24 per cent while the share of the acquired drugs was 21 per cent. 

 In the active pharmaceutical ingredients segment, the companys revenues saw a 44 per cent growth year-on-year at Rs 1,180 crore. 




</TEXT>
</DOC>